Encompass Health Corporation
EHC
Classifica tra le azioni
#1782
Encompass Health Corporation delivers a range of post-acute healthcare services... Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
Prezzo delle azioni
$121.91
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$12.03B
Variazione (1 giorno)
-4.48%
Variazione (1 anno)
-2.63%
Paese
US
Scambia Encompass Health Corporation (EHC)
Categoria
Healthcare
Rapporto P/B per Encompass Health Corporation (EHC)
Rapporto P/B al October 2026 TTM: 4.81
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Encompass Health Corporation, il rapporto P/B attuale (TTM) è 4.81. Alla fine del 2024, era pari a 4.46.
Storico del rapporto P/B per Encompass Health Corporation da 2000 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2026 (TTM) | 4.81 | 44.98% |
| 2025 | 3.32 | -25.72% |
| 2024 | 4.46 | 10.77% |
| 2023 | 4.03 | -11.01% |
| 2022 | 4.53 | 68.47% |
| 2021 | 2.69 | -34.16% |
| 2020 | 4.08 | 2.27% |
| 2019 | 3.99 | 10.47% |
| 2018 | 3.61 | 15.99% |
| 2017 | 3.12 | -21.53% |
| 2016 | 3.97 | -1.91% |
| 2015 | 4.05 | -13.63% |
| 2014 | 4.69 | -12.09% |
| 2013 | 5.33 | 112.84% |
| 2012 | 2.50 | -77.65% |
| 2011 | 11.20 | -162.46% |
| 2010 | -17.94 | 1,218.77% |
| 2009 | -1.36 | 120.04% |
| 2008 | -0.62 | -26.88% |
| 2007 | -0.85 | 29.01% |
| 2006 | -0.66 | -34.63% |
| 2005 | -1.00 | -43.82% |
| 2004 | -1.78 | 18.96% |
| 2003 | -1.50 | -39.95% |
| 2002 | -2.50 | -306.13% |
| 2001 | 1.21 | -14.77% |
| 2000 | 1.42 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| -15.9433 | -431.22% |
US
|
|
| - | - |
DE
|
|
| 4.8701 | 1.18% |
US
|
|
| 9.3882 | 95.04% |
SA
|
|
| 4.6058 | -4.31% |
BR
|
